VERV Recorded Big Gain
Fri, Jun 18, 2021 at 05:33 PM
VERV (VERV:NASDAQ) soared at $38.05, representing a gain of 19.2%.
About VERV (VERV:NASDAQ)
Verve Therapeutics Inc is a genetic medicines company pioneering the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines.
Top 10 Gainers:
- CAI International, Inc. (CAI:NYSE), 46.88%
- Sykes Enterprises, Incorporated (SYKE:NASDAQ), 29.83%
- Geron Corporation (GERN:NASDAQ), 29.79%
- ALF (ALF:NASDAQ), 29.43%
- Luokung Technology Corp. (LKCO:NASDAQ), 22.16%
- VERV (VERV:NASDAQ), 19.2%
- SWBI (SWBI:NASDAQ), 17.22%
- Biophytis SA (BPTS:NASDAQ), 16.51%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 16.11%
- PDS Biotechnology Corporation (PDSB:NASDAQ), 15.78%